Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. (NASDAQ: RDNT) generates a steady flow of news as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of DeepHealth, its AI-powered health informatics division. News about RadNet often highlights developments across its network of 407 owned and/or operated outpatient imaging centers in markets such as Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas, as well as updates from its Digital Health segment.
Investors and observers following RDNT news will encounter announcements on topics such as acquisitions of imaging centers, expansion into new regional markets and updates on RadNet’s operational performance. For example, the company has reported acquisitions like Radiology Regional in Southwest Florida, adding multiple imaging centers and staff to its Florida footprint. Earnings releases and financial guidance updates are also frequent news items, reflecting trends in imaging volumes, segment revenue and Adjusted EBITDA for both the Imaging Center and Digital Health segments.
RadNet’s DeepHealth division is another major source of news, with press releases covering the launch of AI-powered clinical suites, imaging informatics platforms and collaborations with partners. Recent communications have described products such as Breast Suite, Thyroid Suite, Operations Suite, Diagnostic Suite and TechLive, as well as research findings published in scientific journals and showcased at industry conferences like RSNA. News may also cover strategic collaborations, including letters of intent and partnerships with companies such as GE HealthCare to expand AI-powered imaging solutions across modalities and geographies.
Because RadNet regularly issues updates on its financial results, acquisitions, digital health initiatives and research milestones, the RDNT news page can be a useful resource for tracking how the company’s imaging center operations and DeepHealth portfolio evolve over time. Readers interested in diagnostic imaging services, AI in radiology and healthcare operations technology may find RadNet’s news particularly relevant.
RadNet (NASDAQ: RDNT) acquired the assets of Alpha RT to expand DeepHealth’s remote-imaging capabilities, combining Alpha RT’s staffing, training and AI safety monitoring with DeepHealth’s FDA-cleared TechLive™ remote scanning technology.
The combined portfolio supports remote MR, CT, PET and ultrasound scanning from an integrated command center, offers AI-driven MRI safety alerts, vendor-agnostic remote MRI technologist staffing, an MRI Tech Aide Certification program, and intelligent scheduling. Pilot metrics cited: a 0.06% recall rate on remote scans and a 42% reduction in MRI room closures.
RadNet (NASDAQ: RDNT) announced its Investor Day agenda for Tuesday, November 11, 2025, to be held 9:00 a.m.–2:30 p.m. ET at Nasdaq MarketSite in New York City with a live webcast and archived replay available.
Titled “On the Leading Edge of Healthcare: Advancing Imaging Through Innovation and Technology,” the event includes opening remarks and a financial overview, clinical spotlights, digital health and services presentations, demonstrations of DeepHealth AI products (Breast Suite, Diagnostic Suite, TechLive™, Patient Engagement), and two Q&A sessions. In-person attendance is by invitation; investors may request consideration via rdnt@addo.com.
RadNet (NASDAQ: RDNT) will host an Investor Day at the Nasdaq MarketSite in New York City on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. ET. The event will include presentations by senior executives and physician leaders on strategic priorities, market opportunities, and the company’s innovation roadmap.
In-person attendance is by invitation and requires registration. A live webcast and replay, plus slide presentations, will be available via www.radnet.com/investor-day and the company’s Investor Relations page.
RadNet (NASDAQ: RDNT) will host a conference call to discuss its third quarter 2025 financial results on Monday, November 10, 2025 at 7:30 a.m. PT / 10:30 a.m. ET. Investors can join by phone at 844-826-3035 (U.S.) or 412-317-5195 (international).
There will be simultaneous and archived webcasts at https://viavid.webcasts.com/starthere.jsp?ei=1740003&tp_key=5e6a1fc906. An archived phone replay will be available via 844-512-2921 (U.S.) or 412-317-6671 (international) using passcode 10204112.
RadNet (NASDAQ:RDNT), a leading provider of diagnostic imaging services, announced its participation in the upcoming Jefferies Healthcare Services Conference. Dr. Howard Berger, President and CEO, and Mark Stolper, Executive Vice President and CFO, will present on September 29, 2025, at 1:50 PM Central Time in Nashville, TN.
Investors can access the presentation through a simultaneous webcast, which will also be archived for future viewing, available on the company's website under the "About RadNet" section and through the provided webcast link.
RadNet (NASDAQ: RDNT), a leading provider of outpatient diagnostic imaging services, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's senior management team, including CEO Dr. Howard Berger, CFO Mark Stolper, and EVP Mital Patel, will present on September 9th, 2025, at 4:50 PM ET at the Sheraton New York Times Square Hotel.
The presentation will be accessible through a simultaneous webcast and will also be archived for future viewing through the provided webcast link.
RadNet (NASDAQ:RDNT), a leading outpatient diagnostic imaging services provider, reported record Q2 2025 results with total revenue increasing 8.4% to $498.2 million and Adjusted EBITDA growing 12.3% to $81.2 million. The company's Digital Health segment saw significant growth with revenue up 30.9% to $20.7 million.
Advanced imaging volumes showed strong performance, with MRI volume up 9.0%, CT volume up 8.1%, and PET/CT volume surging 22.4%. The company achieved Adjusted Earnings of $23.8 million ($0.31 per share), compared to $12.0 million ($0.16 per share) in Q2 2024.
Based on strong performance, RadNet revised its 2025 guidance upward, with total net revenue now projected at $1.85-1.90 billion and Adjusted EBITDA expected between $271-279 million.
DeepHealth, a RadNet (NASDAQ: RDNT) subsidiary, has received FDA 510(k) clearance for TechLive™, a remote scanning solution for MR, CT, PET/CT, and Ultrasound procedures. The vendor-agnostic platform enables centralized operation and supervision of multiple imaging systems simultaneously.
During a pilot deployment at 64 New York facilities, TechLive™ helped achieve a 42% reduction in MRI room closure hours in Q2 2025 compared to Q2 2024. The system has already been implemented across over 300 RadNet imaging systems, improving operational efficiency and increasing access to complex procedures.
RadNet (NASDAQ:RDNT), a leading provider of diagnostic imaging services and digital health solutions, has scheduled its second quarter 2025 financial results conference call for Monday, August 11, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Investors can participate by dialing 844-826-3035 (US) or 412-317-5195 (International). A simultaneous webcast will be available, and an archived replay can be accessed using the passcode 10201853.
RadNet (NASDAQ:RDNT) has completed the acquisition of iCAD (NASDAQ:ICAD), a global leader in AI-powered breast health solutions, through its wholly-owned subsidiary DeepHealth. The strategic acquisition integrates iCAD's extensive AI portfolio for breast cancer detection with DeepHealth's screening solutions, expanding their reach to over 10 million mammograms annually.
iCAD's technology portfolio, deployed in more than 50 countries across 1,500+ healthcare provider locations, includes solutions for breast cancer detection, risk evaluation, breast density, and arterial calcification assessment. The combination aims to enhance AI model performance and accelerate the adoption of advanced breast cancer screening technologies worldwide, particularly in underserved communities.